211 related articles for article (PubMed ID: 16790692)
41. T-cell leukemia 1 expression in nodal Epstein-Barr virus-negative diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma.
Gualco G; Weiss LM; Barber GN; Bacchi CE
Hum Pathol; 2010 Sep; 41(9):1238-44. PubMed ID: 20382409
[TBL] [Abstract][Full Text] [Related]
42. CD10 antigen expression correlates with the t(14;18)(q32;q21) major breakpoint region in diffuse large B-cell lymphoma.
Fang JM; Finn WG; Hussong JW; Goolsby CL; Cubbon AR; Variakojis D
Mod Pathol; 1999 Mar; 12(3):295-300. PubMed ID: 10102615
[TBL] [Abstract][Full Text] [Related]
43. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas.
Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P
Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071
[TBL] [Abstract][Full Text] [Related]
44. Hypoxia-inducible factor-1alpha expression correlates with focal macrophage infiltration, angiogenesis and unfavourable prognosis in urothelial carcinoma.
Chai CY; Chen WT; Hung WC; Kang WY; Huang YC; Su YC; Yang CH
J Clin Pathol; 2008 May; 61(5):658-64. PubMed ID: 17908805
[TBL] [Abstract][Full Text] [Related]
45. Significantly different bcl-2 expression profiles in gastric and non-gastric primary extranodal high-grade B-cell lymphomas.
Cogliatti SB; Griesser H; Peng H; Du MQ; Isaacson PG; Zimmermann DR; Maibach RC; Schmid U
J Pathol; 2000 Dec; 192(4):470-8. PubMed ID: 11113864
[TBL] [Abstract][Full Text] [Related]
46. Prognostic [corrected] significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature.
Paydas S; Ergin M; Seydaoglu G; Erdogan S; Yavuz S
Leuk Res; 2009 Dec; 33(12):1627-35. PubMed ID: 19286254
[TBL] [Abstract][Full Text] [Related]
47. High level of glutathione-S-transferase pi expression in mantle cell lymphomas.
Bennaceur-Griscelli A; Bosq J; Koscielny S; Lefrère F; Turhan A; Brousse N; Hermine O; Ribrag V
Clin Cancer Res; 2004 May; 10(9):3029-34. PubMed ID: 15131039
[TBL] [Abstract][Full Text] [Related]
48. Tumour proliferation, angiogenesis, and ploidy status in human colon cancer.
Cristi E; Perrone G; Toscano G; Verzì A; Nori S; Santini D; Tonini G; Vetrani A; Fabiano A; Rabitti C
J Clin Pathol; 2005 Nov; 58(11):1170-4. PubMed ID: 16254106
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma.
Llanos M; Alvarez-Argüelles H; Alemán R; Oramas J; Diaz-Flores L; Batista N
Med Oncol; 2001; 18(1):15-22. PubMed ID: 11778965
[TBL] [Abstract][Full Text] [Related]
50. Cortactin expression in non-Hodgkin B-cell lymphomas: a new marker for the differential diagnosis between chronic lymphocytic leukemia and mantle cell lymphoma.
Pizzi M; Trentin L; Visentin A; Saraggi D; Martini V; Guzzardo V; Righi S; Frezzato F; Piazza F; Sabattini E; Semenzato G; Rugge M
Hum Pathol; 2019 Mar; 85():251-259. PubMed ID: 30458196
[TBL] [Abstract][Full Text] [Related]
51. Polyclonal antibody targeting SOX11 cannot differentiate mantle cell lymphoma from B-cell non-Hodgkin lymphomas.
Zhang LN; Cao X; Lu TX; Fan L; Wang L; Xu J; Zhang R; Zou ZJ; Wu JZ; Li JY; Xu W
Am J Clin Pathol; 2013 Dec; 140(6):795-800. PubMed ID: 24225745
[TBL] [Abstract][Full Text] [Related]
52. Comparison of apoptosis and apoptosis-related gene products between extranodal oral B-cell lymphoma and maxillofacial nodal B-cell lymphoma.
Yin H; Okada N; Takagi M
J Oral Pathol Med; 2001 Mar; 30(3):141-7. PubMed ID: 11271628
[TBL] [Abstract][Full Text] [Related]
53. Clinical Significance of VEGF-A and Microvessel Density in Diffuse Large B-Cell Lymphoma and Low-Grade Follicular Lymphoma.
Shahini L; Gašparov S; Petruševska G; Manxhuka Kerliu S; Veselaj F; Kurshumliu F; Kavaja F
Acta Clin Croat; 2017 Dec; 56(4):588-593. PubMed ID: 29590710
[TBL] [Abstract][Full Text] [Related]
54. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
55. Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.
Jørgensen JM; Sørensen FB; Bendix K; Nielsen JL; Funder A; Karkkainen MJ; Tainola T; Sørensen AB; Pedersen FS; D'Amore F
Leuk Lymphoma; 2009 Oct; 50(10):1647-60. PubMed ID: 19701853
[TBL] [Abstract][Full Text] [Related]
56. Aggressive primary cutaneous B-cell lymphomas show increased Angiopoietin-2-induced angiogenesis.
Teichert M; Stumpf C; Booken N; Wobser M; Nashan D; Hallermann C; Mogler C; Müller CS; Becker JC; Moritz RK; Andrulis M; Nicolay JP; Goerdt S; Thomas M; Klemke CD; Augustin HG; Felcht M
Exp Dermatol; 2015 Jun; 24(6):424-9. PubMed ID: 25776770
[TBL] [Abstract][Full Text] [Related]
57. [Expression of Sox11 transcription factor in different types of B-cell lymphomas].
Zhang WM; Wang C; Li BZ
Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):698-9. PubMed ID: 22321551
[No Abstract] [Full Text] [Related]
58. Microvessel density and expression of vascular endothelial growth factor and its receptors in diffuse large B-cell lymphoma subtypes.
Gratzinger D; Zhao S; Marinelli RJ; Kapp AV; Tibshirani RJ; Hammer AS; Hamilton-Dutoit S; Natkunam Y
Am J Pathol; 2007 Apr; 170(4):1362-9. PubMed ID: 17392174
[TBL] [Abstract][Full Text] [Related]
59. [Analysis of microvascular density and the expression of vascular-endothelial growth factor (VEGF) and its membrane receptor Flk-1 in neuroblastoma].
Drozyńska E; Izycka-Swieszewska E; Balcerska A; Bodalski J; Bohosiewicz J; Brozyna A; Bubała H; Chybicka A; Grajkowska W; Koltan S; Madziara W; Rybczyńska A; Słociak M; Sońta-Jakimczyk D; Stolarska M; Perek D; Wachowiak J; Wysocki M
Med Wieku Rozwoj; 2006; 10(3 Pt 1):745-55. PubMed ID: 17317905
[TBL] [Abstract][Full Text] [Related]
60. The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients.
Ganjoo KN; Moore AM; Orazi A; Sen JA; Johnson CS; An CS
J Cancer Res Clin Oncol; 2008 Mar; 134(3):381-7. PubMed ID: 17694324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
